Skip to content

Conventional Vestibular Training Versus Immersive Virtual Reality- Based Vestibular in Multiple Sclerosis

Feasibility and Safety of an Immersive Virtual Reality-based Vestibular Rehabilitation Program for Dizziness, Balance and Fatigue Improvement in People With Multiple Sclerosis: Protocol for a Pilot Randomised Controlled Study

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04497025
Enrollment
0
Registered
2020-08-04
Start date
2026-01-01
Completion date
2029-12-01
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balance Disorders, Cybersickness, Dizziness, Fatigue, Multiple Sclerosis, Quality of Life, Usability, Vestibular Disease

Brief summary

The effectiveness of convectional vestibular training for balance and dizziness rehabilitation in people with multiple sclerosis has been recently demonstrated in a meta-analysis by this research team (doi: 10.3390/jcm9020590). Furthermore, non-immersive virtual reality-based environments seem to be useful for balance and gait rehabilitation in this population (doi: 10.1177/0269215518768084). However, nothing is known about the feasibility and effectiveness of immersive virtual reality-based rehabilitation in people with multiple sclerosis. The primary aim of this research is to determine the feasibility, safety and effectiveness of an immersive virtual reality-based vestibular training for dizziness, balance and fatigue rehabilitation, compared to conventional vestibular training.

Interventions

OTHERImmersive Virtual-based vestibular rehabilitation

Vestibular rehabilitation based on virtual environment using a head mounted display

OTHERConventional vestibular rehabilitation protocol

"Cawthorne-Cooksey" vestibular rehabilitation exercises.

Sponsors

Maria Jesus Casuso-Holgado
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Both male and female subjects from 18-65 years old * Clinically diagnosed with any type of multiple sclerosis in accordance with the revised McDonald criteria * With walking ability according to the Expanded Disability Status Scale score (EDSS =6) * With the objective presence of dizziness symptoms (Dizziness Handicap Inventory = 16)

Exclusion criteria

* Blurred vision * Cognitive impairment (Mini Mental State Examination =24) * Another neurologic disorder contributing to balance impairment * Relapse within the last 3 months * Changes in pharmacotherapy within the last 3 months * History of vestibular rehabilitation within the last 6 months * Acute cardiovascular of respiratory illness * Any other contraindication to physical activity

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of virtual reality-based vestibular rehabilitation7 weeks of interventionUsability of virtual reality device: System Usability Scale (0-100%). Higher Scores means higher usability Participation rate Retention rate Adherence to treatment rate
Safety of virtual reality-based vestibular rehabilitation7 weeks of interventionCybersickness: Scores ranging between 10 and 15 mean significant symptoms and above 20 indicates a simulator problem Falls registry Adverse events registry

Secondary

MeasureTime frameDescription
Change from baseline dizziness symptoms at 7 weeks7 weeks after interventionDizziness Handicap Inventory (0-100 points). Higher scores mean worse dizziness symptoms.
Change from baseline static balance at 7 weeks7 weeks after interventionStatic balance assessed by posturography Dynamic balance assessed by Balance Berg Scale. Higher score better balance.
Change from baseline fatigue at 7 weeks7 weeks after interventionModified Fatigue Impact Scale (0-84 points). Higher scores mean worse fatigue symptoms.
Change from baseline quality of life at 7 weeks7 weeks after interventionMultiple Sclerosis Quality of Life Scale 54 (0-100 points). Higher values indicate better quality of life.

Countries

Spain

Contacts

PRINCIPAL_INVESTIGATORMaria Jesus Casuso-Holgado

University of Seville

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026